MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2235-2241

  Seon, Hee Kim ^a   Bianco, Nicole R ^a   Shufesky, William J ^a   Morelli, Adrian E ^a   Robbins, Paul D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FAS LIGAND; GLYCOPROTEIN P 15095; HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ANTIGEN; CD1 ANTIGEN; CD1B ANTIGEN; FAS ANTIGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL VACUOLE; CONTROLLED STUDY; EXOSOME; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HYPERSENSITIVITY; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADENOVIRUS; ANIMAL; ARTHRITIS; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PLASMA; TRANSPORT VESICLE;

ADENOVIRIDAE; ANIMALS; ANTIGENS; ANTIGENS, CD1; ANTIGENS, CD95; ARTHRITIS, EXPERIMENTAL; DENDRITIC CELLS; FAS LIGAND PROTEIN; HEMOCYANIN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MICE; MICE, INBRED MRL LPR; OVALBUMIN; PLASMA; TRANSDUCTION, GENETIC; TRANSPORT VESICLES;

EID: 34848861342     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2235     Document Type: Article

References (41)

1. Thery, C., M. Boussac, P. Veron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318.
2. Raiborg, C., T. E. Rusten, and H. Stenmark. 2003. Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 15: 446-455.
3. Buschow, S. I., J. M. Liefhebber, R. Wubbolts, and W. Stoorvogel. 2005. Exosomes contain ubiquitinated proteins. Blood Cells Mol. Dis. 35: 398-403.
4. Thery, C., L. Zitvogel, and S. Amigorena. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2: 569-579.
5. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600.
6. Chaput, N., N. E. Schartz, F. Andre, J. Taieb, S. Novault, P. Bonnaventure, N. Aubert, J. Bernard, F. Lemonnier, M. Merad, et al. 2004. Exosomes as potent cell-free peptide-based vaccine: II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172: 2137-2146.
7. Morse, M. A., J. Garst, T. Osada, S. Khan, A. Hobeika, T. M. Clay, N. Valente, R. Shreeniwas, M. A. Sutton, A. Delcayre, et al. 2005. A Phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3: 9.
8. Escudier, B., T. Dorval, N. Chaput, F. Andre, M. P. Caby, S. Novault, C. Flament, C. Leboulaire, C. Borg, S. Amigorena, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first Phase I clinical trial. J. Transl. Med. 3: 10.
9. Altieri, S. L., A. N. Khan, and T. B. Tomasi. 2004. Exosomes from plasmacytoma cells as a tumor vaccine. J. Immunother. 27: 282-288.
10. Aline, F., D. Bout, S. Amigorena, P. Roingeard, and I. Dimier-Poisson. 2004. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 72: 4127-4137.
11. Karlsson, M., S. Lundin, U. Dahlgren, H. Kahu, I. Pettersson, and E. Telemo. 2001. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31: 2892-2900.
12. Peche, H., M. Heslan, C. Usal, S. Amigorena, and M. C. Cuturi. 2003. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76: 1503-1510.
13. Andreola, G., L. Rivoltini, C. Castelli, V. Huber, P. Perego, P. Deho, P. Squarcina, P. Accornero, F. Lozupone, L. Lugini, et al. 2002. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195: 1303-1316.
14. Martinez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monlen, P. Lasierra, L. Larrad, A. Pineiro, M. A. Alava, and J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163: 1274-1281.
15. Abrahams, V. M., S. L. Straszewski, M. Kamsteeg, B. Hanczaruk, P. E. Schwartz, T. J. Rutherford, and G. Mor. 2003. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 63: 5573-5581.
16. Liu, C., S. Yu, K. Zinn, J. Wang, L. Zhang, Y. Jia, J. C. Kappes, S. Barnes, R. P. Kimberly, W. E. Grizzle, and H. G. Zhang. 2006. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176: 1375-1385.
17. Frangsmyr, L., V. Baranov, O. Nagaeva, U. Stendahl, L. Kjellberg, and L. Mincheva-Nilsson. 2005. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod. 11: 35-41.
18. Taylor, D. D., S. Akyol, and C. Gercel-Taylor. 2006. Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol. 176: 1534-1542.
19. Kim, S. H., E. R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S. C. Watkins, A. Gambotto, and P. D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174: 6440-6448.
20. Kim, S. H., N. Bianco, R. Menon, E. R. Lechman, W. J. Shufesky, A. E. Morelli, and P. D. Robbins. 2006. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol. Ther. 13: 289-300.
21. Kim, S. H., N. R. Bianco, W. J. Shufesky, A. E. Morelli, and P. D. Robbins. 2007. Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J. Immunol. 16: 2242-2249.
22. Pisitkun, T., R. F. Shen, and M. A. Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101: 13368-13373.
23. Andre, F., N. E. Schartz, M. Movassagh, C. Flament, P. Pautier, P. Morice, C. Pomel, C. Lhomme, B. Escudier, T. Le Chevalier, et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305.
24. Admyre, C., J. Grunewald, J. Thyberg, S. Gripenback, G. Tornling, A. Eklund, A. Scheynius, and S. Gabrielsson. 2003. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 22: 578-583.
25. Caby, M. P., D. Lankar, C. Vincendeau-Scherrer, G. Raposo, and C. Bonnerot. 2005. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17: 879-887.
26. + T cells by dendritic cell-derived exosomes. Nat. Immunol. 3: 1156-1162.
27. Andre, F., N. Chaput, N. E. Schartz, C. Flament, N. Aubert, J. Bernard, F. Lemonnier, G. Raposo, B. Escudier, D. H. Hsu, et al. 2004. Exosomes as potent cell-free peptide-based vaccine: I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172: 2126-2136.
28. Denzer, K., M. van Eijk, M. J. Kleijmeer, E. Jakobson, C. de Groot, and H. J. Geuze. 2000. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 165: 1259-1265.
29. Morelli, A. E., A. T. Larregina, W. J. Shufesky, M. L. Sullivan, D. B. Stolz, G. D. Papworth, A. F. Zahorchak, A. J. Logar, Z. Wang, S. C. Watkins, et al. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
30. Segura, E., C. Nicco, B. Lombard, P. Veron, G. Raposo, F. Batteux, S. Amigorena, and C. Thery. 2005. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T cell priming. Blood 106: 216-223.
31. Hwang, I., X. Shen, and J. Sprent. 2003. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc. Natl. Acad. Sci. USA 100: 6670-6675.
32. Sprent, J. 2005. Direct stimulation of naive T cells by antigen-presenting cell vesicles. Blood Cells Mol. Dis. 35: 17-20.
33. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172.
34. Admyre, C., S. M. Johansson, S. Paulie, and S. Gabrielsson. 2006. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur. J. Immunol. 36: 1772-1781.
35. + regulatory cells. Scand. J. Immunol. 55: 470-477.
36. + cytotoxic cells. J. Immunol. 174: 4098-4104.
37. Goodnow, C. C., J. Sprent, B. F. de St Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
38. Taylor, D. D., and C. Gercel-Taylor. 2005. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92: 305-311.
39. Meng, Y., S. Kang, and D. A. Fishman. 2005. Lysophosphatidic acid stimulates Fas ligand microvesicle release from ovarian cancer cells. Cancer Immunol. Immunother. 54: 807-814.
40. Martinez-Lorenzo, M. J., A. Anel, M. A. Alava, A. Pineiro, J. Naval, P. Lasierra, and L. Larrad. 2004. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles: possible contribution to tumor counterattack. Exp. Cell Res. 295: 315-329.
41. Feldmann, M., and L. Steinman. 2005. Design of effective immunotherapy for human autoimmunity. Nature 435: 612-619.